LUNG KEE (00255) announced that the company has granted 3 million stock options to certain grantees under its stock option scheme adopted on May 30, 2022. These options carry the right to subscribe for a total of 3 million new ordinary shares in the company's share capital, each with a par value of HK$0.10, subject to acceptance by the grantees.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.